Aralast Related Clinical Trials
A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part I [Not yet recruiting]
Pharmacokinetic Study of Aralast (Human Alpha1- PI) [Completed]
A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part II [Not yet recruiting]
Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation. [Recruiting]
Aralast alpha1-Proteinase Inhibitor Surveillance Study [Active, not recruiting]
The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes [Recruiting]
International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema [Recruiting]
Efficacy and Safety Study of Augmentation Therapy With Aralast (Human Alpha 1 - Proteinase Inhibitor) [Completed]
A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease [Not yet recruiting]
Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency [Recruiting]
Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency [Recruiting]
Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients [Recruiting]
Alpha-1 Coded Testing(ACT) Study [Recruiting]
Liver Disease in Adults With Alpha-1 AT Deficiency [Recruiting]
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis [Recruiting]
Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema [Recruiting]
Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients [Not yet recruiting]
Alpha-1 Foundation Research Registry [Recruiting]
Deposition of Inhaled Prolastin in Cystic Fibrosis Patients [Completed]
The Comparison of the Pharmacokinetic, Safety and Tolerability of Alpha-1 MP and Prolastin in Adult alpha1-Antitrypsin Deficient Patients. [Completed]
Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients [Completed]
Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis [Recruiting]
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency [Not yet recruiting]
Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC) [Recruiting]
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability [Recruiting]
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability [Recruiting]
The Safety and Tolerability of Alpha-1 MP in Subjects With Alpha-1-Antitrypsin (AAT) Deficiency. [Completed]
Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery [Recruiting]
Role of Genetic Factors in the Development of Lung Disease [Recruiting]
A Study of CellCept (Mycophenolate Mofetil) in Lung Transplant Recipients [Recruiting]
Omega 3 Supplementation in Cystic Fibrosis Patients [Recruiting]
A Prospective Study Measuring Exhaled Nitric Oxide in Exercise-Induced Asthma [Not yet recruiting]
|
